These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25134376)

  • 1. The evaluation of serum surfactant protein D (SP-D) levels as a biomarker of lung injury in tuberculosis and different lung diseases.
    Güzel A; Karadağ A; Okuyucu A; Alaçam H; Küçük Y
    Clin Lab; 2014; 60(7):1091-8. PubMed ID: 25134376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.
    Shakoori TA; Sin DD; Ghafoor F; Bashir S; Bokhari SN
    Dis Markers; 2009; 27(6):287-94. PubMed ID: 20075511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
    Kobayashi H; Kanoh S; Motoyoshi K
    Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
    Lomas DA; Silverman EK; Edwards LD; Locantore NW; Miller BE; Horstman DH; Tal-Singer R;
    Eur Respir J; 2009 Jul; 34(1):95-102. PubMed ID: 19164344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes.
    López-Cano C; Lecube A; García-Ramírez M; Muñoz X; Sánchez E; Seminario A; Hernández M; Ciudin A; Gutiérrez L; Hernández C; Simó R
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4109-4116. PubMed ID: 28945872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
    Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
    Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
    Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
    J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
    Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
    Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
    Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
    Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of serum KL-6 glycoprotein or surfactant protein-D in adult T-cell leukemia with distinct pulmonary complications.
    Osaka A; Yanagihara K; Yamada Y; Hasegawa H; Inokuchi N; Hayashi T; Komoda M; Nakamura S; Aoyama M; Sawada T; Kamihira S
    Tohoku J Exp Med; 2009 Jun; 218(2):99-105. PubMed ID: 19478465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD; Orens JB; Bhorade S; Crespo M; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Chest; 2011 Aug; 140(2):489-496. PubMed ID: 21349925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
    Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
    Ju CR; Liu W; Chen RC
    Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.
    Obeidat M; Li X; Burgess S; Zhou G; Fishbane N; Hansel NN; Bossé Y; Joubert P; Hao K; Nickle DC; van den Berge M; Timens W; Cho MH; Hobbs BD; de Jong K; Boezen M; Hung RJ; Rafaels N; Mathias R; Ruczinski I; Beaty TH; Barnes KC; Paré PD; Sin DD;
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29191953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.
    Duvoix A; Miranda E; Perez J; Sorensen GL; Holmskov U; Trapnell BC; Madsen J; Clark HW; Edwards LD; Miller BE; Tal-Singer RM; Lomas DA
    COPD; 2011 Apr; 8(2):79-95. PubMed ID: 21495836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.
    Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].
    Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Ogura T
    Kekkaku; 2014 Jul; 89(7):637-42. PubMed ID: 25195297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux].
    Sosnovskaya AV; Fomin VV; Popova EN; Lebedeva MV; Moiseev SV; Svistunov AA; Mukhin NA
    Ter Arkh; 2015; 87(3):42-47. PubMed ID: 26027239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of the serum surfactant protein D (Sp-D) level to indicate lung injury in pulmonary embolism.
    Kati C; Alacam H; Duran L; Guzel A; Akdemir HU; Sisman B; Sahin C; Yavuz Y; Altintas N; Murat N; Okuyucu A
    Clin Lab; 2014; 60(9):1457-64. PubMed ID: 25291941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.